Answer
Apr 22, 2026 - 02:13 PM
Do you have the same question? Follow this Question
Apr 22, 2026 - 02:13 PM
We’ve provided several answers to questions related to Cimzia (Certolizumab Pegol) , see some other helpful Q&A related to this product.
Question: What is the US regulatory approval status for this medication?
Answer: It is approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Regulatory approval from major agencies ensures the medication has undergone rigorous safety and efficacy testing.
Question: What is the protein binding rate of the Fab’ fragment?
Answer: The protein binding rate of the Fab' fragment is approximately 95%. High protein binding can affect the drug’s distribution and duration of action, which may influence dosing intervals.